美敦力创新加速器

MEDTRONIC MEDTECH INNOVATION ACCELERATOR

以“创新、共享、加速”为定位，协同企业资源与政府服务

美敦力创新加速器简介

美敦力创新加速器是美敦力设立在中国上海的一个创新孵化加速平台，其目的是促进更多医疗技术在中国市场转化为有价值的医疗产品和服务，成为可供患者选择的、高效的健康解决方案，同时为中国推进建设全球科技创新中心打造可持续的发展力。

美敦力创新加速器由美敦力大中华区建立，获得了临港集团和闵行区政府的支持。它毗邻美敦力中国研发中心，座落于上海临港浦江国际科技城，已投入使用的一期设施占地1000平方米，有可供10家医疗技术创业企业自用的研发及行政基础设施模块，还能够利用美敦力的研发网络中的强大资源。

美敦力创新加速器于2019年3月25日正式启用。

以“创新、共享、加速”为定位，协同企业资源与政府服务

美敦力创新加速器致力于赋能拥有产品转化潜力的早期阶段医疗技术创业公司，帮助实现从实验室到市场的创新成熟与成果转化，通过服务患者和提升行业能力来创造价值。

创新

发挥创新专长：背靠美敦力公司近70年来在70多种疾病治疗领域的创新资产，以及包括中国在内的150个国家和地区的市场经验，美敦力创新加速器将致力于发掘有意义的医疗科技创新项目，促进项目从成长走向成功，从本土走向全球，实现价值提升，造福全球患者。

关注创新前沿：美敦力创新加速器关注能够改善患者生命的医疗科技创新前沿，包括人工智能、机器人、生物工程、新材料等广泛领域；优先支持在国际范围内具有突破性、颠覆性潜力，并能够填补国内市场未满足需求的本土或国际医疗创新项目。

共享

共享资源：美敦力创新加速器的合作伙伴能够有机会使用加速器的办公与实验空间，并有机会享受美敦力中国研发中心实验设备的测试服务与专家咨询服务。除早期研发支持外，美敦力还将选择优质项目，与其共享美敦力的丰富资源，为具有市场前景的医疗创新提供临床试验、上市注册等辅导；利用公司在华生产基地，提供创新生产解决方案；开放美敦力自有的临床培训中心，支持合作企业开展相关临床技能培训。

上海临港经济发展（集团）有限公司旗下的浦江国际科技城，具备强大的集团背景与对政策的精准把握，美敦力创新加速器的入驻企业将有机会获得其提供的包括人力、财务、知识产权、法律、政府项目申报、投融资服务在内的基础企业服务以及股权融资、上市财务顾问及科技项目申报在内的增值服务。

共享价值：美敦力期望通过创新加速器激发医疗科技的更多潜能，与合作伙伴携手提升患者的治疗效果与医疗经济效益，为中国建设富有全球吸引力的科创中心贡献力量。

 加速

加速转化：赋能具有较高临床与市场潜力的早期阶段医疗技术创业公司，帮助其加速从实验室到市场的创新成果转化，缩短从创新项目到成熟疗法的开发过程。

加速应用：借助美敦力注册经验和市场网络，加速先进医疗科技的落地与应用，为患者带来更多高效健康解决方案，促进本土医疗创新的可持续发展。

延伸创新战略布局，完善全创新周期的协作平台

随着美敦力创新加速器的启用，美敦力在中国的创新协作平台实现了从种子轮到成熟产品的覆盖，有机会与不同阶段的医疗技术创新企业开展协作。

美敦力创新加速器 主要面向创业早期企业，帮助其加速完善产品和进行临床审批所需的准备工作；

美敦力中国基金主要面向产品进入上市准备期的企业，为其提供资金和市场策略支持；

美敦力业务发展部门主要面向具备成熟产品的企业，通过并购或代理销售为产品拓宽市场渠道。

 

MEDTRONIC MEDTECH INNOVATION ACCELERATOR INTRODUCTION

Medtronic MedTech Innovation Accelerator, located in Shanghai, is a platform for empowering collaborative innovation. As a Medtronic initiative, it will accelerate the conversion of bright ideas into valuable medical products and services, serving the China market with accessible medical solutions to improve patient outcomes. Medtronic MedTech Innovation Accelerator will also contribute to China’s goal to become a science and technology innovation hub with global influence.

As an addition to the Medtronic Greater China network, Medtronic MedTech Innovation Accelerator has received endorsement from Minhang District government of Shanghai and Lingang Economic Development (Group) Co., Ltd. It is located close to the Medtronic China R&D Center in Pujiang International Science and Technology City, Minhang District, Shanghai, and boasts 1,000 square meters during the first phase of its establishment. Its facilities and equipment are made available to 10 Medtronic MedTech Innovation Accelerator portfolio companies for their R&D and administrative work, when these companies are also granted access to strong resources in the Medtronic R&D network.

Medtronic MedTech Innovation Accelerator starts operation officially on March 25, 2019.

Synergizing businesses and government resources for “Innovating, Sharing, Accelerating”

Medtronic MedTech Innovation Accelerator is committed to empowering early-stage MedTech start-ups with strong potential to transform technologies in labs into accessible medical solutions and creating value by serving patient needs and evolving industry capabilities.

Innovating

Leveraging Expertise in Innovation

Medtronic MedTech Innovation Accelerator takes advantage of the company’s 70-year innovation heritage and assets across more than 70 therapeutic areas and its operation footprint across more than 150 countries and markets, including China. It is dedicated to identifying meaningful medtech innovation and helping it to grow and enable its access to markets and to patients.

Featuring Emerging Innovation

Medtronic MedTech Innovation Accelerator will be focused on a wide range of emerging medtech that can improve lives, such as artificial intelligence, surgical robotics, bioengineering, and new materials. It will prioritize support for medical applications that present prospective ground-breaking or disruptive innovations across the world, as well as capabilities in narrowing the gap for serving Chinese patients.

Sharing

Sharing Resources

Medtronic MedTech Innovation Accelerator portfolio companies are granted a workplace for coworking and R&D, access to advanced lab equipment at the Medtronic Technology Center, and advice from Medtronic China R&D staff. On top of the support in early-stage innovation, other potential Medtronic support for promising programs includes guidance on clinical research, product registration, outsourced manufacturing solutions, and professional clinical education of physician customers at the company’s clinical training centers in China.

Pujiang International Science and Technology City, owned by Shanghai Lingang Economic Development (Group) Co., Ltd., boasts a strong network and deep understanding of policies. It provides Medtronic MedTech Innovation Accelerator portfolio companies with added value through services ranging from human resources, finance, intellectual property, legal, government project declaration, investment and funding to equity financing, listing financial advisory, and science & technology project applications.

Sharing Values

Through its partnerships that are set to unleash further medtech potential, Medtronic MedTech Innovation Accelerator is expected to improve patient outcomes and the healthcare system’s economic value, as well as contribute to China’s goal of becoming a science and technology innovation hub with global influence.

Accelerating

Accelerating Conversion

Empower early-stage MedTech start-ups, with real potential in clinical outcomes and market performance, accelerating the process from an idea in a lab, to an accessible therapy in the market.

Accelerating Application

Tapping into Medtronic’s rich experience in product registration and market access, realize localization and application in a shorter time, so that patients can benefit from more efficient medical solutions while enabling a thriving environment for innovation.

Evolving innovation strategy with enforced collaborative platform covering the full lifecycle of innovation

The addition of Medtronic MedTech Innovation Accelerator to the company’s collaborative innovation network enables more capabilities for medtech start-ups in different business stages, supporting their innovation from the ideation stage through to marketable products.

Medtronic MedTech Innovation Accelerator

Mainly supports early-stage start-ups to optimize their products and prepare for clinical trials.

Medtronic China Venture Fund

Mainly provides support in funding and marketing strategy for partnering businesses with products to be marketed.

Medtronic Business Development Function

Mainly partners with businesses with marketed products to expand their market access through acquisitions or dealer agreements.